Evaluation of clinical outcomes in patients treated with heparin or direct thrombin inhibitors during extracorporeal membrane oxygenation: a systematic review and meta-analysis

BACKGROUND: The number of patients treated with extracorporeal membrane oxygenation (ECMO) devices is increasing. Anticoagulation therapy is crucial to prevent thrombosis during ECMO therapy. Predominantly, heparin has been used as primary anticoagulant but direct thrombin inhibitors (DTI) have been...

Descripción completa

Detalles Bibliográficos
Autores principales: M’Pembele, René, Roth, Sebastian, Metzger, Aljoscha, Nucaro, Anthony, Stroda, Alexandra, Polzin, Amin, Hollmann, Markus W., Lurati Buse, Giovanna, Huhn, Ragnar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9330661/
https://www.ncbi.nlm.nih.gov/pubmed/35902857
http://dx.doi.org/10.1186/s12959-022-00401-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9330661/
https://www.ncbi.nlm.nih.gov/pubmed/35902857
http://dx.doi.org/10.1186/s12959-022-00401-2

Ejemplares similares